Company Analysis Organon & Co.
1. Summary
Advantages
- Price (16.13 $) is less than fair price (17.64 $)
- Dividends (6.42%) are higher than the sector average (1.3%).
- The stock's return over the last year (-13.18%) is higher than the sector average (-16.29%).
Disadvantages
- Current debt level 72.65% has increased over 5 years from 0.986%.
- The company's current efficiency (ROE=-1461.43%) is lower than the sector average (ROE=-82.41%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
Organon & Co. | Healthcare | Index | |
---|---|---|---|
7 days | -1.3% | -14% | -2.8% |
90 days | -3.1% | -17% | -2.9% |
1 year | -13.2% | -16.3% | 15.5% |
OGN vs Sector: Organon & Co. has outperformed the "Healthcare" sector by 3.11% over the past year.
OGN vs Market: Organon & Co. has significantly underperformed the market by -28.66% over the past year.
Stable price: OGN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: OGN with weekly volatility of -0.2535% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (16.13 $) is lower than the fair price (17.64 $).
Price not significantly lower than the fair price: The current price (16.13 $) is slightly lower than the fair price by 9.4%.
4.2. P/E
P/E vs Sector: The company's P/E (3.54) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (3.54) is lower than that of the market as a whole (73.51).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (-51.73) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (-51.73) is lower than that of the market as a whole (22.32).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.5782) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (0.5782) is lower than that of the market as a whole (15.92).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.53) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (7.53) is lower than that of the market as a whole (22.62).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -10.53% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-10.53%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (-1461.43%) is lower than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (-1461.43%) is lower than that of the market as a whole (25.01%).
5.5. ROA
ROA vs Sector: The company's ROA (8.48%) is higher than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (8.48%) is higher than that of the market as a whole (6.62%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (13.88%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (13.88%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 6.42% is higher than the average for the sector '1.3%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 6.42% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 6.42% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (28.74%) are at a comfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
Transaction date | Insider | Type | Price | Volume | Quantity |
---|---|---|---|---|---|
04.05.2024 | Stahler Rachel A Chief Information Officer |
Purchase | 20.4 | 62 200 | 3 049 |
04.05.2024 | WALSH MATTHEW M Chief Financial Officer |
Purchase | 20.4 | 169 524 | 8 310 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription